The point discussed is not whether it works or not, but what are the actual safety parameters.
That's not a "Pfizer's is slightly safer in 30+ males and should be used preferentially in that population if both are available" safety quibble.
That's not a "Pfizer's is slightly safer in 30+ males and should be used preferentially in that population if both are available" safety quibble.